نتایج جستجو برای: depot medroxyprogesterone acetate dmpa
تعداد نتایج: 54340 فیلتر نتایج به سال:
OBJECTIVE To estimate 24-month continuation rates of all reversible contraceptive methods for women enrolled in the Contraceptive CHOICE Project. METHODS We analyzed 24-month data from the 9,256 participants enrolled in the Contraceptive CHOICE Project, a prospective observational cohort study that provides no-cost contraception to women in the St. Louis region. The project promoted the use o...
BACKGROUND The rate of unintended pregnancy in the United States is much higher than in other developed nations. Approximately half of unintended pregnancies are due to contraceptive failure, largely owing to inconsistent or incorrect use. METHODS We designed a large prospective cohort study to promote the use of long-acting reversible contraceptive methods as a means of reducing unintended p...
CONTEXT Hormonal contraceptive users may be at increased risk for HIV and other STDs. An understanding of their decisions and abilities to use condoms is needed to focus intervention programs aimed at improving their protective behaviors. METHODS Between 1999 and 2001, 426 new users of depot medroxyprogesterone acetate (DMPA) and oral contraceptives were recruited from public clinics providin...
Journal of Family Planning and Reproductive Health Care 2003: 29(3) Clinical scenario A 30-year-old woman consults you. She has been successfully using a progesterone-only pill (POP) containing levonorgestrel (LNG) (Microval®) but is anxious that her POP has a higher failure rate than her previous combined oral contraceptive pill (COC). She would prefer to continue some form of POP, having disl...
Unintended pregnancies, which accounted for an estimated 49% of all pregnancies in the United States in 2001, more often are associated with adverse outcomes for both mother and child than are intended pregnancies. In 2008, an estimated 36 million U.S. women of reproductive age were in need of family planning services because they were sexually active, able to get pregnant, and not trying to ge...
Implanon, an Etonogestrel capsule, containing 68 mg of the synthetic progestin etonogestrel implant, was first introduced in Indonesia in 1998 and approved for use in the U.S. in 2006, as a subcutaneous hormone eluting capsule providing longacting reversible contraception (LARC) [1-4]. Prior to the use of Implanon, short-acting reversible contraceptives (SARC) such as oral contraceptive pills (...
Family Planning Perspectives In the early 1990s, the U.S. Food and Drug Administration approved subdermal contraceptive implants and the injectable contraceptive depot medroxy progesterone acetate (DMPA), adding two long-term methods to the array of contraceptives currently available. A primary concern associated with these highly effective methods is that, as has been documented among women wh...
Background Hysterosalpingram (HSG) evaluation of tubal patency is typically performed in the follicular phase, but data to support this timing are lacking. Purpose To determine whether menstrual cycle phase or hormonal treatments affect observation of tubal patency during HSG. Material and Methods Ten participants underwent repeated HSG examinations: during the follicular and luteal phase of a ...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید